Mechanisms underlying regional differences in lipolysis in human adipose tissue.

Catecholamine-induced lipolysis was investigated in nonobese females and males. Isolated subcutaneous adipocytes were obtained from the abdominal and gluteal regions. The lipolytic effect of noradrenaline was four to fivefold more marked in abdominal adipocytes than in gluteal fat cells. This regional difference was more apparent in females than in males. No site differences were observed when lipolysis was stimulated with agents acting at different postreceptor levels. The beta-adrenergic lipolytic sensitivity was 10-20 times greater in abdominal adipocytes from both sexes than in gluteal adipocytes. Abdominal adipocytes from females showed a 40 times lower alpha 2-adrenergic antilipolytic sensitivity than did gluteal adipocytes, but the adenosine receptor sensitivity was similar in both sites. Beta-receptor affinity for agonists displayed no site or sex variation. Abdominal adipocytes showed a twofold increased beta-adrenoceptor density than did gluteal cells from both sexes. The alpha 2-adrenoceptor density was similar in all regions, but in females the affinity of clonidine for these sites was 10-15 times lower in the abdominal fat cells compared with gluteal cells. In conclusion, regional differences in catecholamine-induced lipolysis are regulated at the adrenoceptor level, chiefly because of site variations in beta-adrenoceptor density. Further variations in the affinity properties of alpha 2-adrenergic receptor in females may explain why the regional differences in catecholamine-induced lipolysis are more pronounced in women than in men.

[1]  L. Sjöström,et al.  Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. , 1983, The Journal of clinical investigation.

[2]  R. Leibel,et al.  Site- and sex-related differences in adrenoreceptor status of human adipose tissue. , 1987, The Journal of clinical endocrinology and metabolism.

[3]  P. Arner,et al.  Determination of adrenoceptors of the alpha 2-subtype on isolated human fat cells. , 1983, Scandinavian journal of clinical and laboratory investigation.

[4]  R. Hoffmann,et al.  Relationship of androgenic activity to body fat topography, fat cell morphology, and metabolic aberrations in premenopausal women. , 1983, The Journal of clinical endocrinology and metabolism.

[5]  P. Arner,et al.  Sensitive kinetic bioluminescent assay of glycerol release from human fat cells. , 1981, Journal of lipid research.

[6]  M. Rodbell METABOLISM OF ISOLATED FAT CELLS. I. EFFECTS OF HORMONES ON GLUCOSE METABOLISM AND LIPOLYSIS. , 1964, The Journal of biological chemistry.

[7]  Y. Giudicelli,et al.  "Spare" beta-adrenergic receptors of rat white adipocyte membranes. , 1984, Biochemistry international.

[8]  P. Arner,et al.  Regional differences in the control of lipolysis in human adipose tissue. , 1979, Metabolism: clinical and experimental.

[9]  H. Kather,et al.  Human fat cell adenylate cyclase: regional differences in adrenaline responsiveness , 1977, European journal of clinical investigation.

[10]  K. Jakobs,et al.  Human fat cell lipolysis is primarily regulated by inhibitory modulators acting through distinct mechanisms. , 1985, The Journal of clinical investigation.

[11]  P. Arner,et al.  Influence of fasting on lipolytic response to adrenergic agonists and on adrenergic receptors in subcutaneous adipocytes , 1984, European journal of clinical investigation.

[12]  H. Porzig Are there differences in the β-receptor-adenylate cyclase systems of fragmented membranes and living cells? , 1982 .

[13]  P. Arner,et al.  Adrenoceptor occupancy in isolated human fat cells and its relationship with lipolysis rate. , 1988, European journal of pharmacology.

[14]  M. Berlan,et al.  Alpha‐adrenergic antilipolytic effect of adrenaline in human fat cells of the thigh: comparison with adrenaline responsiveness of different fat deposits , 1979, European journal of clinical investigation.

[15]  K. Pennert,et al.  Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. , 1984, British medical journal.

[16]  P. Arner,et al.  Relationship between the tissue level of cyclic AMP and the fat cell size of human adipose tissue. , 1978, Journal of lipid research.

[17]  T. Burns,et al.  Lipolysis by human adipose tissue: the role of cyclic 3',5'-adenosine monophosphate and adrenergic receptor sites. , 1970, The Journal of laboratory and clinical medicine.

[18]  D Rodbard,et al.  Ligand: a versatile computerized approach for characterization of ligand-binding systems. , 1980, Analytical biochemistry.

[19]  S. Efendić,et al.  Catecholamines and metabolism of human adipose tissue. II. Effect of isoprophylnoradrenaline and adrenergic blocking agents on lipolysis in human omental adipose tissue in vitro. , 2009, Acta medica Scandinavica.

[20]  P. Arner,et al.  Changes in catecholamine-induced lipolysis in isolated human fat cells during the first year of life. , 1987, The Journal of clinical investigation.

[21]  J. Daly,et al.  Forskolin: unique diterpene activator of adenylate cyclase in membranes and in intact cells. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[22]  B. Fredholm,et al.  The effect of alkylxanthines and other phosphodiesterase inhibitors on adenosine-receptor mediated decrease in lipolysis and cyclic AMP accumulation in rat fat cells. , 2009, Acta pharmacologica et toxicologica.

[23]  M. Berlan,et al.  Heterogeneous distribution of beta and alpha‐2 adrenoceptor binding sites in human fat cells from various fat deposits: functional consequences , 1987, European journal of clinical investigation.

[24]  P. Björntorp,et al.  Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. , 1984, British medical journal.

[25]  J. Fain,et al.  Adrenergic regulation of adipocyte metabolism. , 1983, Journal of lipid research.